Despite advances in surgical techniques, postoperative complications such as infection, retained foreign body, seroma or hematoma may lead to the development of a sinus tract. A sinus tract, also referred to as wound tunneling, is a cutaneous opening with a narrow passageway that tracks in one direction underneath the tissues and is oftentimes blind ended or accompanied by drainage. Conservative wound care failure may necessitate further surgical interventions that are associated with high risk for complications and prolonged hospitalization. The purpose of the published study was to assess the clinical utility of placental products as an alternative to surgical treatment for refractory cutaneous sinus tracts of surgical origin in twelve patients. The primary clinical analysis was the proportion of complete sinus tract depth resolution without exudate. Six patients received a viable
cryopreserved placental membrane (vCPM) (Grafix®;
Grafix is a cryopreserved placental membrane comprised of an extracellular matrix (ECM) rich in collagen, growth factors, and viable cells native to the tissue. Grafix is processed using Osiris' proprietary technology; it is flexible and conforming and designed as a wound cover/barrier for application directly to hard-to-treat acute and chronic wounds, including but not limited to diabetic foot ulcers, venous leg ulcers and thermal burns.
This press release contains forward-looking statements. Forward-looking statements include statements about our expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts. Words or phrases such as "anticipate," "believe," "continue," "ongoing," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project" or similar words or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Examples of forward-looking statements may include, without limitation, statements regarding the anticipated efficiencies and advantages of products or services and the likelihood of customer clinical adoption of new services. Although well characterized in scientific literature and studies, preservation of tissue integrity including cells may not be indicative of clinical outcome. Accordingly, you should not unduly rely on these forward-looking statements. We undertake no obligation to publicly revise any forward-looking statement to reflect circumstances or events after the date of this press release or to reflect the occurrence of unanticipated events.
For additional information, please contact:
News Provided by Acquire Media